AGX812
SARS-CoV-2 Nucleoprotein (aa 1-419) Recombinant Antigen, 613
suitable for immunodiffusion
別名:
2019-nCoV, COVID-19
ログインで組織・契約価格をご覧ください。
サイズを選択してください
表示を変更する
この商品について
NACRES:
NA.26
UNSPSC Code:
51201600
recombinant
expressed in E. coli
Quality Segment
form
liquid
mol wt
≤72 kDa
storage condition
avoid repeated freeze/thaw cycles
technique(s)
immunodiffusion: suitable, lateral flow assay: suitable
shipped in
dry ice
General description
Coronavirus disease 2019 (COVID-19) is an infectious disease caused by the virus strain severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. A SARS-CoV-2 nucleoprotein antigen can be used to support the detection of SARS-CoV-2 (COVID-19, 2019-nCoV).
SARS-CoV-2 Nucleoprotein (aa 1-419) Recombinant Antigen, expressed in E. coli, Cat. No. AGX812 is for use in Lateral Flow Assay.
Physical form
Purified protein in 10mM Phosphate Buffered Saline without preservatives, pH 7.4.
Preparation Note
Please refer to guidance on suggested starting dilutions and/or titers per application and sample type.
Stable for 1 year at -10°C to -25°C from date of receipt. Avoid repeated freeze/thaw cycles.
Disclaimer
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
保管分類
12 - Non Combustible Liquids
wgk
WGK 2
flash_point_f
Not applicable
flash_point_c
Not applicable